Company: INDP
Filing Date: 2025-08-13
Form Type: S-3
Source: 0001641172-25-023499
Chunk: 27

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-08-13
Form: S-3
Chunk 27
---
 ● 
 ● | our                                                                                                                                   
 Annual Report on Form 10-K for the year ended December 31, 2024 (filed with the SEC on March 13, 2025);                               
 our                                                                                                                                   
 Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025 (filed with the SEC on May 14, 2025) and June 30, 2025 (filed    
 with the SEC on August 13, 2025);                                                                                                     |
|:--|:--------------------------------------------------------------------------------------------------------------------------------------|
| ● | our                                                                                                                                   
 Current Reports on Form 8-K (other than portions thereof furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits accompanying 
 such reports that relate to such items) filed with the SEC on January 14, 2025, January 31, 2025, February 12, 2025, March 13, 2025,  
 May 14, 2025, June 11, 2025, June 13, 2025, June 26, 2025, July 1, 2025, July 16, 2025 and July 29, 2025;                             |
| ● | our                                                                                                                                   
 annual Proxy Statement on Schedule 14A relating to our annual meeting of stockholders, filed on April 28, 2025 (with respect to those 
 portions incorporated by reference into our Annual Report on Form 10-K for the year ended December 31, 2024).                         |
| ● | the                                                                                                                                   
 description of our shares of common stock contained in Item 1 of the Registration Statement on Form 8-A (File No. 001-40652), filed   
 with the SEC on July 23, 2021, including any amendment or report filed for the purpose of updating such description.                  |

| 22 |

We are not, however, incorporating, in each case, any documents or information that we are deemed to furnish and not file in accordance with SEC rules.

Any statement contained in any document incorporated by reference herein will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus or any prospectus supplement modifies or supersedes such statement. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus.

All reports and other documents we